Schwœbel, V., Trébucq, A., Kashongwe, Z., Bakayoko, A. S., Kuaban, C., Noeske, J., . . . Rieder, H. L. (2020). Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries. EClinicalMedicine, 20, 100268. https://doi.org/10.1016/j.eclinm.2020.100268
Citace podle Chicago (17th ed.)Schwœbel, Valérie, et al. "Outcomes of a Nine-month Regimen for Rifampicin-resistant Tuberculosis Up to 24 Months After Treatment Completion in Nine African Countries." EClinicalMedicine 20 (2020): 100268. https://doi.org/10.1016/j.eclinm.2020.100268.
Citace podle MLA (9th ed.)Schwœbel, Valérie, et al. "Outcomes of a Nine-month Regimen for Rifampicin-resistant Tuberculosis Up to 24 Months After Treatment Completion in Nine African Countries." EClinicalMedicine, vol. 20, 2020, p. 100268, https://doi.org/10.1016/j.eclinm.2020.100268.